Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Boschetti, Elisa ^a,b   D'Alessandro, Roberto ^a   Bianco, Francesca ^a   Carelli, Valerio ^b   Cenacchi, Giovanna ^b   Pinna, Antonio D ^a   Del Gaudio, Massimo ^a   Rinaldi, Rita ^c   Stanghellini, Vincenzo ^a   Pironi, Loris ^a   Rhoden, Kerry ^a   Tugnoli, Vitaliano ^b   Casali, Carlo ^d   De Giorgio, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THYMIDINE PHOSPHORYLASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; MALE; MNGIE SYNDROME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; DUODENUM; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHY; PATHOLOGY; SKELETAL MUSCLE;

ADULT; BLOTTING, WESTERN; DUODENUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MUSCLE, SKELETAL; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE;

EID: 84900534923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096692     Document Type: Article

References (38)

1. DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348: 2656-2668. (Pubitemid 36741594)
2. Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283: 689-692.
3. Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, et al. (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277: 4128-4133. (Pubitemid 34968672)
4. Marti R, Nishigaki Y, Hirano M (2003) Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun 303: 14-18. (Pubitemid 36338200)
5. Ferraro P, Pontarin G, Crocco L, Fabris S, Reichard P, et al. (2005) Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 280: 24472-24480. (Pubitemid 40934532)
6. Gonzalez-Vioque E, Torres-Torronteras J, Andreu AL, Marti R (2011) Limited dCTP availability accounts for mitochondrial DNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). PLoS Genet 7: e1002035.
7. Song S, Wheeler LJ, Mathews CK (2003) Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 278: 43893-43896. (Pubitemid 37377127)
8. Pontarin G, Ferraro P, Valentino ML, Hirano M, Reichard P, et al. (2006) Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 281: 22720-22728.
9. Giordano C, Sebastiani M, De Giorgio R, Travaglini C, Tancredi A, et al. (2008) Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 173: 1120-1128.
10. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, et al. (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44: 721-727. (Pubitemid 24130006)
11. Papadimitriou A, Comi GP, Hadjigeorgiou GM, Bordoni A, Sciacco M, et al. (1998) Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 51: 1086-1092. (Pubitemid 28473405)
12. Marti R, Verschuuren JJ, Buchman A, Hirano I, Tadesse S, et al. (2005) Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol 58: 649-652. (Pubitemid 41377233)
13. Lara MC, Valentino ML, Torres-Torronteras J, Hirano M, Marti R (2007) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep 27: 151-163. (Pubitemid 46940943)
14. la Marca G, Malvagia S, Casetta B, Pasquini E, Pela I, et al. (2006) Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS. J Mass Spectrom 41: 586-592. (Pubitemid 44023113)
15. Yavuz H, Ozel A, Christensen M, Christensen E, Schwartz M, et al. (2007) Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 64: 435-438. (Pubitemid 46425702)
16. Lara MC, Weiss B, Illa I, Madoz P, Massuet L, et al. (2006) Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 67: 1461-1463. (Pubitemid 44632074)
17. Fairbanks LD, Levene M, Bax BE (2013) Validation of a HPLC method for the measurement of erythrocyte encapsulated thymidine phosphorylase (EE-TP) activity. J Pharm Biomed Anal 76: 8-12.
18. Torres-Torronteras J, Gomez A, Eixarch H, Palenzuela L, Pizzorno G, et al. (2011) Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther 18: 795-806.
19. Torres-Torronteras J, Viscomi C, Cabrera-Perez R, Camara Y, Di Meo I, et al. (2014) Gene Therapy Using a Liver-targeted AAV Vector Restores Nucleoside and Nucleotide Homeostasis in a Murine Model of MNGIE. Mol Ther. e-Pub
20. Halter J, Schupbach WM, Casali C, Elhasid R, Fay K, et al. (2011) Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 46: 330-337.
21. Hirano M, Marti R, Casali C, Tadesse S, Uldrick T, et al. (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67: 1458-1460. (Pubitemid 44632073)
22. Filosto M, Scarpelli M, Tonin P, Lucchini G, Pavan F, et al. (2012) Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol 259: 2699-2706.
23. O'Mahony CA, Goss JA (2012) The future of liver transplantation. Tex Heart Inst J 39: 874-875.
24. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
25. Friedkin M, Roberts D (1954) The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. J Biol Chem 207: 257-266.
26. Hirano M, Nishigaki Y, Marti R (2004) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10: 8-17. (Pubitemid 38140835)
27. Wu SL, Pan CE (2013) Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation. World J Gastroenterol 19: 5981-5987.
28. Finkenstedt A, Schranz M, Bosch S, Karall D, Burgi SS, et al. (2013) MNGIE Syndrome: Liver Cirrhosis Should Be Ruled Out Prior to Bone Marrow Transplantation. JIMD Rep 10: 41-44.
29. Friedkin M, Roberts D (1954) The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue. J Biol Chem 207: 245-256.
30. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, et al. (1990) Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034: 107-113. (Pubitemid 20114807)
31. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, et al. (1995) Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55: 1687-1690.
32. Akiyama S, Furukawa T, Sumizawa T, Takebayashi Y, Nakajima Y, et al. (2004) The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. Cancer Sci 95: 851-857. (Pubitemid 40045518)
33. van Triest B, Pinedo HM, Blaauwgeers JL, van Diest PJ, Schoenmakers PS, et al. (2000) Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. Clin Cancer Res 6: 1063-1072. (Pubitemid 30159368)
34. Bonotto M, Bozza C, Di Loreto C, Osa EO, Poletto E, et al. (2013) Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase? Clin Breast Cancer 13: 167-172.
35. Toi M, Atiqur Rahman M, Bando H, Chow LW (2005) Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol 6: 158-166. (Pubitemid 40309127)
36. Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51: 212-223.
37. Waltenberger J, Usuki K, Fellstrom B, Funa K, Heldin CH (1992) Platelet-derived endothelial cell growth factor. Pharmacokinetics, organ distribution and degradation after intravenous administration in rats. FEBS Lett 313: 129-132.
38. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, et al. (1995) Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 176: 183-190.